Évolution de la résistance aux antituberculeux au Canada. : données supplémentaires
![RMTC](/content/dam/phac-aspc/images/services/reports-publications/canada-communicable-disease-report-ccdr/rmtc-wordmark1140.jpg)
Volume 43-11, le 2 novembre 2017 : La résistance au antimicrobiens et l’approche « Une Santé »
Sur le Web seulement
La résistance aux antituberculeux au Canada : Données supplémentaires de 2006 à 2016
V Gallant1, J Vachon1*, W Siu1
Affiliation
1 Centre de la lutte contre les maladies transmissibles et les infections, Agence de la santé publique du Canada, Ottawa (Ontario)
Correspondance
Citation proposée
V Gallant, J Vachon, W Siu. La résistance aux antituberculeux au Canada : Données supplémentaires de 2006 à 2016. Relevé des maladies transmissibles au Canada. 2017;43(11). Sur le Web seulement. https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/resistance-antituberculeux-canada-donnees-supplementaires-2006-2016.html
Année | Nombre total d'isolats CMBT déclarés | Résistants à un ou plusieurs antituberculeux majeurs | Tuberculose multirésistanteTableau 1 note * | Tuberculose ultrarésistanteTableau 1 note † | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
2006 | 1,389 | 126 | 9.1 | 15 | 1.1 | 1 | 0.1 |
2007 | 1,267 | 133 | 10.5 | 11 | 0.9 | 0 | 0.0 |
2008 | 1,356 | 116 | 8.6 | 15 | 1.1 | 1 | 0.1 |
2009 | 1,331 | 127 | 9.5 | 18 | 1.4 | 0 | 0.0 |
2010 | 1,274 | 112 | 8.8 | 17 | 1.3 | 1 | 0.1 |
2011 | 1,319 | 139 | 10.5 | 18 | 1.4 | 1 | 0.1 |
2012 | 1,404 | 139 | 9.9 | 8 | 0.6 | 1 | 0.1 |
2013 | 1,371 | 112 | 8.2 | 14 | 1.0 | 1 | 0.1 |
2014 | 1,370 | 130 | 9.5 | 18 | 1.3 | 1 | 0.1 |
2015 | 1,339 | 139 | 10.4 | 22 | 1.6 | 0 | 0.0 |
2016 | 1,452 | 130 | 9.0 | 17 | 1.2 | 0 | 0.0 |
TOTAL | 14,872 | 1,403 | 9.4 | 173 | 1.2 | 7 | Moins de 0.1 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TOTAL | |||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Nombre total d’isolats testés | 1,389 | 100.0 | 1,267 | 100.0 | 1,356 | 100.0 | 1,331 | 100.0 | 1,274 | 100.0 | 1,319 | 100.0 | 1,404 | 100.0 | 1,371 | 100.0 | 1,370 | 100.0 | 1,339 | 100.0 | 1,452 | 100.0 | 14,872 | 100.0 |
Isolats testés qui étaient sensibles | 1,263 | 90.9 | 1,134 | 89.5 | 1,240 | 91.4 | 1,204 | 90.5 | 1,162 | 91.2 | 1,180 | 89.5 | 1,265 | 90.1 | 1,259 | 91.8 | 1,240 | 90.5 | 1,200 | 89.6 | 1,322 | 91.0 | 13,469 | 90.6 |
Isolats affichant une certaine résistance aux antituberculeux majeurs | ||||||||||||||||||||||||
Toute résistance à l’isoniazide | 101 | 7.3 | 110 | 8.7 | 102 | 7.5 | 113 | 8.5 | 101 | 7.9 | 122 | 9.2 | 111 | 7.9 | 93 | 6.8 | 106 | 7.7 | 110 | 8.2 | 113 | 7.8 | 1,182 | 7.9 |
Toute résistance à la rifampicine | 24 | 1.7 | 13 | 1.0 | 19 | 1.4 | 21 | 1.6 | 18 | 1.4 | 21 | 1.6 | 10 | 0.7 | 17 | 1.2 | 24 | 1.8 | 24 | 1.8 | 18 | 1.2 | 209 | 1.4 |
Toute résistance à l’éthambutol | 12 | 0.9 | 23 | 1.8 | 13 | 1.0 | 17 | 1.3 | 10 | 0.8 | 9 | 0.7 | 4 | 0.3 | 10 | 0.7 | 6 | 0.4 | 10 | 0.7 | 10 | 0.7 | 124 | 0.8 |
Toute résistance à la pyrazinamideTableau 2 note * | 16 | 1.5 | 27 | 2.7 | 22 | 2.1 | 18 | 1.7 | 25 | 2.4 | 28 | 2.3 | 33 | 2.8 | 26 | 2.2 | 30 | 2.6 | 38 | 3.4 | 38 | 3.0 | 301 | 2.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 126 | 9.1 | 133 | 10.5 | 116 | 8.6 | 127 | 9.5 | 112 | 8.8 | 139 | 10.5 | 139 | 9.9 | 112 | 8.2 | 130 | 9.5 | 139 | 10.4 | 130 | 9.0 | 1,403 | 9.4 |
Monorésistance | 107 | 7.7 | 111 | 8.8 | 94 | 6.9 | 98 | 7.4 | 88 | 6.9 | 119 | 9.0 | 128 | 9.1 | 93 | 6.8 | 107 | 7.8 | 114 | 8.5 | 108 | 7.4 | 1,167 | 7.8 |
MultirésistanceTableau 2 note † | 15 | 1.1 | 11 | 0.9 | 15 | 1.1 | 18 | 1.4 | 17 | 1.3 | 18 | 1.4 | 8 | 0.6 | 14 | 1.0 | 18 | 1.3 | 22 | 1.6 | 17 | 1.2 | 173 | 1.2 |
Polyrésistance | 3 | 0.2 | 11 | 0.9 | 6 | 0.4 | 11 | 0.8 | 6 | 0.5 | 1 | 0.1 | 2 | 0.1 | 4 | 0.3 | 4 | 0.3 | 3 | 0.2 | 5 | 0.3 | 56 | 0.4 |
UltrarésistancetTableau 2 note ‡ | 1 | 0.1 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 1 | 0.1 | 1 | 0.1 | 1 | 0.1 | 1 | 0.1 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 7 | < 0.1 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 3 note * | 104 | 100.0 | 98 | 100.0 | 134 | 100.0 | 159 | 100.0 | 107 | 100.0 | 156 | 100.0 | 163 | 100.0 | 154 | 100.0 | 181 | 100.0 | 185 | 100.0 | 206 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 95 | 91.3 | 92 | 93.9 | 123 | 91.8 | 145 | 91.2 | 96 | 89.7 | 133 | 85.3 | 148 | 90.8 | 140 | 90.9 | 165 | 91.2 | 164 | 88.6 | 194 | 94.2 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 7 | 6.7 | 5 | 5.1 | 8 | 6.0 | 8 | 5.0 | 6 | 5.6 | 14 | 9.0 | 10 | 6.1 | 9 | 5.8 | 11 | 6.1 | 15 | 8.1 | 7 | 3.4 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 1 | 1.0 | 1 | 1.0 | 0 | 0 | 3 | 1.9 | 0 | 0 | 2 | 1.3 | 3 | 1.8 | 4 | 2.6 | 0 | 0 | 3 | 1.6 | 0 | 0 |
Sous-total - tuberculose monorésistante | 8 | 7.7 | 6 | 6.1 | 8 | 6.0 | 12 | 7.5 | 6 | 5.6 | 16 | 10.3 | 13 | 8.0 | 13 | 8.4 | 12 | 6.6 | 18 | 9.7 | 7 | 3.4 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et EMB | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 1.0 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, EMB et PZA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.9 | 0 | 0 | 0 | 0 | 1 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 |
INH et PZA | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.6 | 1 | 0.9 | 0 | 0 | 1 | 0.6 | 0 | 0 | 0 | 0 | 1 | 0.5 | 0 | 0 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 1 | 0.7 | 2 | 1.3 | 2 | 1.9 | 0 | 0.0 | 1 | 0.6 | 1 | 0.6 | 0 | 0.0 | 1 | 0.5 | 1 | 0.5 |
Tuberculose multirésistanteTableau 3 note † | ||||||||||||||||||||||
INH et RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB et PZA | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, RMP, EMB, PZA, SM, OFL et MOX | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, OFL, MOX , ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM et RBT | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 | 1 | 0.9 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, et SM | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, ETH, RBT et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, RMP, et ETH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
INH, RMP, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.3 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 2 | 1.0 |
INH, RMP, PZA, SM et ETH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, OFL et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total - tuberculose multirésistante | 1 | 1.0 | 0 | 0.0 | 2 | 1.5 | 0 | 0.0 | 3 | 2.8 | 7 | 4.5 | 1 | 0.6 | 0 | 0.0 | 4 | 2.2 | 2 | 1.1 | 4 | 1.9 |
Tuberculose ultrarésistanteTableau 3 note ‡ | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 9 | 8.7 | 6 | 6.1 | 11 | 8.2 | 14 | 8.8 | 11 | 10.3 | 23 | 14.7 | 15 | 9.2 | 14 | 9.1 | 16 | 8.8 | 21 | 11.4 | 12 | 5.8 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 4 note *Tableau 4 note † | 275 | 100.0 | 231 | 100.0 | 254 | 100.0 | 239 | 100.0 | 201 | 100.0 | 194 | 100.0 | 254 | 100.0 | 213 | 100.0 | 264 | 100.0 | 231 | 100.0 | 217 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 257 | 93.5 | 210 | 90.9 | 230 | 90.6 | 215 | 90.0 | 182 | 90.6 | 170 | 87.6 | 231 | 90.9 | 194 | 91.1 | 230 | 87.1 | 199 | 86.2 | 196 | 90.3 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 7 | 2.6 | 13 | 5.6 | 18 | 7.1 | 22 | 9.2 | 16 | 8.0 | 21 | 10.8 | 21 | 8.3 | 19 | 8.9 | 24 | 9.1 | 27 | 11.7 | 15 | 6.9 |
RMP | 6 | 2.2 | 0 | 0.0 | 3 | 1.2 | 1 | 0.4 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 2 | 0.8 | 1 | 0.4 | 0 | 0.0 |
EMB | 3 | 1.1 | 4 | 1.7 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 1 | 0.5 |
Sous-total - tuberculose monorésistante | 16 | 5.8 | 17 | 7.4 | 21 | 8.3 | 23 | 9.6 | 18 | 9.0 | 22 | 11.3 | 21 | 8.3 | 19 | 8.9 | 26 | 9.8 | 29 | 12.6 | 16 | 7.4 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et EMB | 0 | 0 | 2 | 0.9 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 1 | 0.5 |
INH et PZA | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 2 | 0.8 | 0 | 0.0 | 2 | 0.9 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 2 | 0.9 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 2 | 0.8 | 1 | 0.4 | 3 | 1.4 |
Tuberculose multirésistanteTableau 4 note ‡ | ||||||||||||||||||||||
INH et RMP | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, KM, CM, ETH et RBT | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA et PAS | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA et RBT | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, ETH, RBT et PAS | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, KM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, OFL, ETH , RBT et PAS | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, OFL et MOX | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, RMP, EMB, SM, AK, KM, CM , ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 |
INH, RMP, EMB, SM, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 1 | 0.4 | 0 | 0.0 |
INH, RMP, PZA et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, RBT et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, RBT | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 0.8 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 | 0 | 0.0 | 1 | 0.5 |
Sous-total - tuberculose multirésistante | 2 | 0.7 | 2 | 0.9 | 3 | 1.2 | 0 | 0.0 | 1 | 0.5 | 1 | 0.5 | 2 | 0.8 | 0 | 0.0 | 6 | 2.3 | 2 | 0.9 | 2 | 0.9 |
Tuberculose ultrarésistante Tableau 4 note ** | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 18 | 6.5 | 21 | 9.1 | 24 | 9.4 | 24 | 10.0 | 19 | 9.5 | 24 | 12.4 | 23 | 9.1 | 19 | 8.9 | 34 | 12.9 | 32 | 13.9 | 21 | 9.7 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 5 note * | 119 | 100.0 | 84 | 100.0 | 116 | 100.0 | 106 | 100.0 | 113 | 100.0 | 97 | 100.0 | 123 | 100.0 | 148 | 100.0 | 125 | 100.0 | 129 | 100.0 | 168 | 100 |
Isolats sensibles à tous les antituberculeux majeurs | 113 | 95.0 | 75 | 89.3 | 111 | 95.7 | 99 | 93.4 | 99 | 87.6 | 90 | 92.8 | 113 | 91.9 | 144 | 97.3 | 120 | 96.0 | 125 | 96.9 | 156 | 92.3 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 6 | 5.0 | 7 | 8.3 | 4 | 3.4 | 4 | 3.8 | 10 | 8.8 | 5 | 5.2 | 10 | 8.1 | 4 | 2.7 | 5 | 4.0 | 3 | 2.3 | 6 | 3.6 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 1 | 1.2 | 0 | 0.0 | 1 | 0.9 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 1.8 |
Sous-total - tuberculose monorésistante | 6 | 5.0 | 8 | 9.5 | 4 | 3.4 | 5 | 4.7 | 11 | 9.7 | 5 | 5.2 | 10 | 8.1 | 4 | 2.7 | 5 | 4.0 | 3 | 2.3 | 9 | 5.3 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et EMB | 0 | 0.0 | 1 | 1.2 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH et PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 1 | 1.2 | 0 | 0.0 | 2 | 1.9 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 |
Tuberculose multirésistanteTableau 5 note † | ||||||||||||||||||||||
INH et RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, AK, KM, CM, ETH et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, KM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 |
INH, RMP, PZA, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 |
INH, RMP, PZA, SM et RBT | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 |
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 1 | 0.9 | 2 | 2.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 2 | 1.2 |
Tuberculose ultrarésistanteTableau 5 note ‡ | ||||||||||||||||||||||
INH, RMP, EMB, PZA, KM, OFL, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 6 | 5.0 | 9 | 10.7 | 5 | 4.3 | 7 | 6.6 | 14 | 12.4 | 7 | 7.2 | 10 | 8.1 | 4 | 2.7 | 5 | 4.0 | 4 | 3.1 | 12 | 7.1 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 6 note * | 3 | 100.0 | 5 | 100.0 | 3 | 100.0 | 10 | 100.0 | 9 | 100.0 | 5 | 100.0 | 4 | 100.0 | 3 | 100.0 | 6 | 100.0 | 7 | 100.0 | 9 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 3 | 100.0 | 5 | 100.0 | 3 | 100.0 | 10 | 100.0 | 7 | 77.8 | 5 | 100.0 | 3 | 75.0 | 2 | 66.7 | 6 | 100.0 | 5 | 71.4 | 0 | 0.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 1 | 14.3 | 0 | 0.0 |
Sous-total - tuberculose monorésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 25.0 | 1 | 33.3 | 0 | 0.0 | 1 | 14.3 | 0 | 0.0 |
Tuberculose polyrésistante | ||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 6 note † | ||||||||||||||||||||||
INH, RMP, PZA, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 14.3 | 0 | 0.0 |
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 14.3 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 6 note ‡ | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 25.0 | 1 | 33.3 | 0 | 0.0 | 2 | 28.6 | 0 | 0.0 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZA | 11 | 100.0 | 5 | 100.0 | 5 | 100.0 | 10 | 100.0 | 9 | 100.0 | 5 | 100.0 | 5 | 100.0 | 11 | 100.0 | 6 | 100.0 | 21 | 100.0 | 18 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 11 | 100.0 | 5 | 100.0 | 5 | 100.0 | 10 | 100.0 | 9 | 100.0 | 5 | 100.0 | 5 | 100.0 | 11 | 100.0 | 6 | 100.0 | 21 | 100.0 | 18 | 100.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total - tuberculose monorésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose polyrésistante | ||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 7 note * | ||||||||||||||||||||||
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 7 note † | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZA | 4 | 100.0 | 14 | 100.0 | 13 | 100.0 | 10 | 100.0 | 5 | 100.0 | 8 | 100.0 | 6 | 100.0 | 3 | 100.0 | 2 | 100.0 | 4 | 100.0 | 4 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 3 | 75.0 | 14 | 100.0 | 13 | 100.0 | 9 | 90.0 | 4 | 80.0 | 8 | 100.0 | 6 | 100.0 | 3 | 100.0 | 2 | 100.0 | 4 | 100.0 | 4 | 100.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 20.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 10.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total - tuberculose monorésistante | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 1 | 10.0 | 1 | 20.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose polyrésistante | ||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 8 note * | ||||||||||||||||||||||
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 8 note † | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 1 | 10.0 | 1 | 20.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 9 note * | 8 | 100.0 | 5 | 100.0 | 3 | 100.0 | 7 | 100.0 | 8 | 100.0 | 7 | 100.0 | 9 | 100.0 | 9 | 100.0 | 8 | 100.0 | 7 | 100.0 | 3 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 8 | 100.0 | 5 | 100.0 | 3 | 100.0 | 7 | 100.0 | 5 | 62.5 | 7 | 100.0 | 9 | 100.0 | 8 | 88.9 | 5 | 62.5 | 7 | 100.0 | 2 | 66.7 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 12.5 | 0 | 0.0 | 0 | 0.0 | 1 | 11.1 | 3 | 37.5 | 0 | 0.0 | 0 | 0.0 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 12.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 33.3 |
Sous-total - tuberculose monorésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 25.0 | 0 | 0.0 | 0 | 0.0 | 1 | 11.1 | 3 | 37.5 | 0 | 0.0 | 1 | 33.3 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 12.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 12.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 9 note † | ||||||||||||||||||||||
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 9 note ‡ | ||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 37.5 | 0 | 0.0 | 0 | 0.0 | 1 | 11.1 | 3 | 37.5 | 0 | 0.0 | 1 | 33.3 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZA | 28 | 100.0 | 37 | 100.0 | 25 | 100.0 | 51 | 100.0 | 50 | 100.0 | 71 | 100.0 | 64 | 100.0 | 65 | 100.0 | 42 | 100.0 | 66 | 100.0 | 35 | 100.0 | 33 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 28 | 100.0 | 37 | 100.0 | 24 | 96.0 | 51 | 100.0 | 49 | 98.0 | 70 | 98.6 | 62 | 96.9 | 65 | 100.0 | 42 | 100.0 | 66 | 100.0 | 33 | 94.3 | 33 | 100.0 |
Tuberculose monorésistante | ||||||||||||||||||||||||
INH | 0 | 0.0 | 0 | 0.0 | 1 | 4.0 | 0 | 0.0 | 1 | 2.0 | 1 | 1.4 | 1 | 1.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 5.7 | 0 | 0.0 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total - tuberculose monorésistante | 0 | 0.0 | 0 | 0.0 | 1 | 4.0 | 0 | 0.0 | 1 | 2.0 | 1 | 1.4 | 2 | 3.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 5.7 | 0 | 0.0 |
Polyrésistance | ||||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 10 note * | ||||||||||||||||||||||||
Sous-total - tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 10 note † | ||||||||||||||||||||||||
Sous-total - tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0.0 | 0 | 0.0 | 1 | 4.0 | 0 | 0.0 | 1 | 2.0 | 1 | 1.4 | 2 | 3.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 5.7 | 0 | 0.0 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB, au PZATableau 11 note * | 567 | 100.0 | 538 | 100.0 | 479 | 100.0 | 488 | 100.0 | 496 | 100.0 | 507 | 100.0 | 493 | 100.0 | 511 | 100.0 | 457 | 100.0 | 480 | 100.0 | 505 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 504 | 88.9 | 466 | 86.6 | 427 | 89.1 | 428 | 87.7 | 456 | 91.9 | 454 | 89.6 | 429 | 87.0 | 458 | 89.6 | 407 | 89.1 | 421 | 87.7 | 453 | 89.7 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 39 | 6.9 | 50 | 9.3 | 33 | 6.9 | 39 | 8.0 | 27 | 5.4 | 39 | 7.7 | 45 | 9.1 | 27 | 5.3 | 30 | 6.6 | 30 | 6.3 | 43 | 8.5 |
RMP | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 2 | 0.4 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 |
EMB | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 9 | 1.6 | 9 | 1.7 | 6 | 1.3 | 4 | 0.8 | 2 | 0.4 | 6 | 1.2 | 10 | 2.0 | 8 | 1.6 | 11 | 2.4 | 15 | 3.1 | 1 | 0.2 |
Sous-total, tuberculose monorésistante | 49 | 8.6 | 61 | 11.3 | 40 | 8.4 | 44 | 9.0 | 29 | 5.8 | 45 | 8.9 | 57 | 11.6 | 37 | 7.2 | 42 | 9.2 | 45 | 9.4 | 45 | 8.9 |
Tuberculose polyrésistante | ||||||||||||||||||||||
EMB, PZA | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, EMB | 3 | 0.7 | 1 | 0.2 | 2 | 0.4 | 3 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, EMB, et PZA | 0 | 0.0 | 0 | 0.0 | 2 | 0.4 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, PZA | 0 | 0.0 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 2 | 0.4 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose polyrésistante | 3 | 0.5 | 4 | 0.7 | 4 | 0.8 | 5 | 1.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 3 | 0.6 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 11 note * | ||||||||||||||||||||||
INH, RMP | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, AK, CM, et RBT | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, CM, et RBT | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, EMB, PZA, AK, CM, ETH, et RBT | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, CM, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, ETH, et RBT | 0 | 0.0 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, et RBT | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, EMB, PZA, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, et SM | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, AK, KM, CM, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, EMB, PZA, SM, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, OFL, MOX, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, OFL, MOX, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, EMB, PZA, SM, et RBT | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 3 | 0.6 | 0 | 0.0 |
INH, RMP, EMB, et RBT | 1 | 0.4 | 1 | 0.2 | 1 | 0.2 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, AK, et CM | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, ETH, RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, KM, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, OFL, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, OFL, MOX, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, ETH, et RBT | 2 | 0.4 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, OFL, ETH, RBT, et PAS | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, PZA, ETH, et RBT | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, AK, KM, CM, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, PZA, SM, ETH, et RBT | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, PZA, SM, OFL, MOX, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 |
INH, RMP, et RBT | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, et SM | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, CM, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 |
INH, RMP, SM, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, KM, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, OFL, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, SM, et RBT | 0 | 0.0 | 0 | 0.0 | 3 | 0.6 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 1 | 0.2 | 2 | 0.4 | 1 | 0.2 | 5 | 1.0 | 0 | 0.0 |
Sous-total, tuberculose multirésistante | 10 | 1.8 | 7 | 1.3 | 7 | 1.5 | 11 | 2.3 | 10 | 2.0 | 7 | 1.4 | 5 | 1.0 | 13 | 2.5 | 6 | 1.3 | 14 | 2.9 | 7 | 1.4 |
Tuberculose ultrarésistanteTableau 11 note † | ||||||||||||||||||||||
INH, RMP, AK, CM, OFL, ETH, et RBT | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, CM, OFL, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, KM, OFL, MOX, ETH, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, KM, OFL, MOX, ETH, RBT, et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, KM, OFL, MOX, et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose ultrarésistante | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 63 | 11.1 | 72 | 13.4 | 52 | 10.9 | 60 | 12.3 | 40 | 8.1 | 53 | 10.5 | 64 | 13.0 | 53 | 10.4 | 50 | 10.9 | 59 | 12.3 | 52 | 10.3 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB, au PZA | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 100.0 | 1 | 100.0 | 3 | 100.0 | 0 | 0 | 0 | 0 | 2 | 100.0 | 2 | 100.0 | 4 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 100.0 | 1 | 100.0 | 2 | 66.7 | 0 | 0 | 0 | 0 | 2 | 100.0 | 2 | 100.0 | 4 | 100.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
RMP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 1 | 33.3 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose monorésistante | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 1 | 33.3 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose polyrésistante | ||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 12 note * | ||||||||||||||||||||||
Sous-total, tuberculose multirésistante | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 12 note † | ||||||||||||||||||||||
Sous-total, tuberculose ultrarésistante | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 1 | 33.3 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB et au PZATableau 13 note * | 201 | 100.0 | 200 | 100.0 | 210 | 100.0 | 171 | 100.0 | 197 | 100.0 | 205 | 100.0 | 209 | 100.0 | 205 | 100.0 | 186 | 100.0 | 185 | 100.0 | 215 | 100 |
Isolats sensibles à tous les antituberculeux majeurs | 173 | 86.1 | 177 | 88.5 | 188 | 89.5 | 156 | 91.2 | 179 | 90.9 | 180 | 87.8 | 187 | 89.5 | 187 | 91.2 | 167 | 89.8 | 167 | 90.3 | 187 | 87.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 21 | 10.4 | 12 | 6.0 | 15 | 7.1 | 7 | 4.1 | 11 | 5.6 | 18 | 8.8 | 13 | 6.2 | 12 | 5.9 | 10 | 5.4 | 8 | 4.3 | 17 | 7.9 |
RMP | 1 | 0.5 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 4 | 2.0 | 4 | 2.0 | 4 | 1.9 | 2 | 1.2 | 5 | 2.5 | 6 | 2.9 | 9 | 4.3 | 4 | 2.0 | 7 | 3.8 | 6 | 3.2 | 9 | 4.2 |
Sous-total, tuberculose monorésistante | 26 | 12.9 | 17 | 8.5 | 19 | 9.0 | 9 | 5.3 | 16 | 8.1 | 24 | 11.7 | 22 | 10.5 | 16 | 7.8 | 17 | 9.1 | 15 | 8.1 | 26 | 12.1 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et EMB | 0 | 0.0 | 3 | 1.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
INH et PZA | 0 | 0.0 | 1 | 0.5 | 1 | 0.5 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 4 | 2.0 | 1 | 0.5 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
Tuberculose multirésistanteTableau 13 note † | ||||||||||||||||||||||
INH, RMP, EMB, ETH et RBT | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB et PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
INH, RMP, EMB, PZA et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM et ETH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM, KM, ETH, RBT et PAS | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, PZA, SM et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB et RBT | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, EMB, SM et RBT | 1 | 0.5 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 |
INH, RMP, PZA et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, AK, KM et CM | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP, PZA, SM, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, RMP, PZA, SM, KM, CM et ETH | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 |
INH, RMP, SM et RBT | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 2 | 1.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose multirésistante | 2 | 1.0 | 2 | 1.0 | 2 | 1.0 | 6 | 3.5 | 1 | 0.5 | 1 | 0.5 | 0 | 0.0 | 1 | 0.5 | 2 | 1.1 | 2 | 1.1 | 2 | 0.9 |
Tuberculose ultrarésistanteTableau 13 note ‡ | ||||||||||||||||||||||
INH, RMP, EMB, PZA, SM, AK, KM, CM, OFL, MOX, ETH et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 28 | 13.9 | 23 | 11.5 | 22 | 10.5 | 15 | 8.8 | 18 | 9.1 | 25 | 12.2 | 22 | 10.5 | 18 | 8.8 | 19 | 10.2 | 18 | 9.7 | 28 | 15.1 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB, au PZA | 58 | 100.0 | 60 | 100.0 | 81 | 100.0 | 77 | 100.0 | 54 | 100.0 | 66 | 100.0 | 72 | 100.0 | 71 | 100.0 | 63 | 100.0 | 50 | 100.0 | 65 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 57 | 98.3 | 59 | 98.3 | 79 | 97.5 | 72 | 93.5 | 51 | 94.4 | 62 | 93.9 | 68 | 94.4 | 69 | 97.2 | 60 | 95.2 | 49 | 98.0 | 62 | 95.4 |
Tuberculose monorésistante | ||||||||||||||||||||||
INH | 1 | 1.7 | 1 | 1.7 | 2 | 2.5 | 3 | 3.9 | 2 | 3.7 | 4 | 6.1 | 1 | 1.4 | 1 | 1.4 | 0 | 0.0 | 0 | 0.0 | 2 | 3.1 |
RMP | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.6 | 0 | 0.0 | 0 | 0.0 |
EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 4.2 | 1 | 1.4 | 1 | 1.6 | 1 | 2.0 | 1 | 1.5 |
Sous-total, tuberculose monorésistante | 1 | 1.7 | 1 | 1.7 | 2 | 2.5 | 3 | 3.9 | 2 | 3.7 | 4 | 6.1 | 4 | 5.6 | 2 | 2.8 | 2 | 3.2 | 1 | 2.0 | 3 | 4.6 |
Tuberculose polyrésistante | ||||||||||||||||||||||
INH et EMB | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH et PZA | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.6 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.6 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 14 note * | ||||||||||||||||||||||
INH, RMP et RBT | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
INH, RMP et SM | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sous-total, tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.3 | 1 | 1.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 14 note † | ||||||||||||||||||||||
Sous-total, tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 1 | 1.7 | 1 | 1.7 | 2 | 2.5 | 5 | 6.5 | 3 | 5.6 | 4 | 6.1 | 4 | 5.6 | 2 | 2.8 | 3 | 4.8 | 1 | 2.0 | 3 | 4.6 |
Caractéristiques d’isolats | Année de déclaration | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Isolats soumis à des tests de résistance à l’INH, à la RMP, à l’EMB, au PZATableau 15 note * | 2 | 100.0 | 2 | 100.0 | 7 | 100.0 | 3 | 100.0 | 5 | 100.0 | 2 | 100.0 | 1 | 100.0 | 1 | 100.0 | 4 | 100.0 | 3 | 100.0 | 2 | 100.0 |
Isolats sensibles à tous les antituberculeux majeurs | 2 | 100.0 | 2 | 100.0 | 7 | 100.0 | 3 | 100.0 | 5 | 100.0 | 2 | 100.0 | 1 | 100.0 | 1 | 100.0 | 4 | 100.0 | 3 | 100.0 | 2 | 100.0 |
Tuberculose monorésistante | ||||||||||||||||||||||
Sous-total, tuberculose monorésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose polyrésistante | ||||||||||||||||||||||
Sous-total, tuberculose polyrésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose multirésistanteTableau 15 note † | ||||||||||||||||||||||
Sous-total, tuberculose multirésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Tuberculose ultrarésistanteTableau 15 note ‡ | ||||||||||||||||||||||
Sous-total, tuberculose ultrarésistante | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nombre total d’isolats résistants à un ou plusieurs antituberculeux majeurs | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Province/territoire de déclarationTableau 16 note * | Canada | Province/territoire d'origine | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T.-N.-L. | Î.-P.-É. | N.-É. | N.B. | Qc | Ont. | Man. | Sask. | Alb. | C.-B. | Yn | T.N.-O. | Nt. | ||
T.-N.-L. | 18 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
N.-É. | 7 | 0 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
N.B. | 9 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Qc | 215 | 0 | 0 | 0 | 0 | 215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ont. | 536 | 0 | 0 | 0 | 0 | 3 | 504 | 0 | 0 | 0 | 0 | 0 | 0 | 29 |
Man. | 168 | 0 | 0 | 0 | 0 | 0 | 0 | 168 | 0 | 0 | 0 | 0 | 0 | 0 |
Sask. | 63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63 | 0 | 0 | 0 | 0 | 0 |
Alb. | 216 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 206 | 0 | 0 | 4 | 4 |
C.- B. | 220 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 217 | 2 | 0 | 0 |
TOTAL | 1,452 | 18 | 4 | 3 | 9 | 218 | 505 | 168 | 65 | 206 | 217 | 2 | 4 | 33 |
Isolats | Canada | Province/territoire d'origine | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T.-N.-L. | Î.-P.-É. | N.-É. | N.-B. | Qc | Ont. | Man. | Sask. | Alb. | C.-B. | Yn | T.N.-O. | Nt | ||
INH et RMP | 6 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 2 | 1 | 0 | 0 | 0 |
INH, RMP et EMB | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
INH, RMP, EMB et PZA | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
INH, RMP et PZA | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Nombre total d’isolats de tuberculose multirésistanteTableau 17 note * | 17 | 0 | 0 | 0 | 0 | 2 | 7 | 2 | 0 | 4 | 2 | 0 | 0 | 0 |
Tuberculose ultrarésistanteTableau 17 note † | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Province/territoire d'origine | Nombre total d’isolats du CMTB déclarés | Résistants à un ou plusieurs antituberculeux majeurs | Tuberculose multirésistanteTableau 18 note * | Tuberculose ultrarésistanteTableau 18 note † | |||
---|---|---|---|---|---|---|---|
Nombre | Pourcentage (%) | Nombre | Pourcentage (%) | Nombre | Pourcentage (%) | ||
Ontario | 5,521 | 618 | 11.2 | 97 | 1.8 | 5 | 0.1 |
Colombie-Britannique | 2,573 | 259 | 10.1 | 21 | 0.8 | 0 | 0.0 |
Québec | 2,187 | 237 | 10.8 | 21 | 1.0 | 1 | 0.0 |
Alberta | 1,647 | 152 | 9.2 | 24 | 1.5 | 0 | 0.0 |
Manitoba | 1,328 | 83 | 6.3 | 7 | 0.5 | 1 | 0.1 |
Saskatchewan | 717 | 29 | 4.0 | 2 | 0.3 | 0 | 0.0 |
Nunavut | 537 | 7 | 1.3 | 0 | 0.0 | 0 | 0.0 |
Terre-Neuve-et-Labrador | 106 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Nouvelle-Écosse | 74 | 8 | 10.8 | 0 | 0.0 | 0 | 0.0 |
Territoires du Nord-Ouest | 73 | 3 | 4.1 | 0 | 0.0 | 0 | 0.0 |
Nouveau-Brunswick | 64 | 6 | 9.4 | 1 | 1.6 | 0 | 0.0 |
Yukon | 32 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Île-du-Prince-Édouard | 13 | 1 | 7.7 | 0 | 0.0 | 0 | 0.0 |
Canada | 14,872 | 1,403 | 9.4 | 173 | 1.2 | 7 | 0.0 |
Groupe d’âge et sexe | Isolats déclarés | Résistants à un ou plusieurs antituberculeux majeurs | Tuberculose multirésistanteTableau 19 note * | Tuberculose ultrarésistanteTableau 19 note † | |||||
---|---|---|---|---|---|---|---|---|---|
Nombre | Pourcentage (%) | Nombre | Pourcentage (%) | Nombre | Pourcentage (%) | Nombre | Pourcentage (%) | ||
Moins de 1 ans | Hommes | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Femmes | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 2 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
1 à 4 ans | Hommes | 5 | 0.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Femmes | 6 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | |
Total | 11 | 0.8 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | |
5 à 14 ans | Hommes | 11 | 0.8 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 |
Femmes | 11 | 0.8 | 3 | 2.3 | 1 | 5.9 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 22 | 1.5 | 4 | 3.1 | 1 | 5.9 | 0 | 0.0 | |
15 à 24 ans | Hommes | 112 | 7.7 | 11 | 8.5 | 1 | 5.9 | 0 | 0.0 |
Femmes | 95 | 6.5 | 14 | 10.8 | 3 | 17.6 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 207 | 14.3 | 25 | 19.2 | 4 | 23.5 | 0 | 0.0 | |
25 à 34 ans | Hommes | 126 | 8.7 | 8 | 6.2 | 2 | 11.8 | 0 | 0.0 |
Femmes | 160 | 11.0 | 18 | 13.8 | 2 | 11.8 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 286 | 19.7 | 26 | 20.0 | 4 | 23.5 | 0 | 0.0 | |
35 à 44 ans | Hommes | 98 | 6.7 | 6 | 4.6 | 0 | 0.0 | 0 | 0.0 |
Femmes | 84 | 5.8 | 12 | 9.2 | 4 | 23.5 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 182 | 12.5 | 18 | 13.8 | 4 | 23.5 | 0 | 0.0 | |
45 à 54 ans | Hommes | 104 | 7.2 | 11 | 8.5 | 1 | 5.9 | 0 | 0.0 |
Femmes | 71 | 4.9 | 5 | 3.8 | 1 | 5.9 | 0 | 0.0 | |
Renseignement non disponible | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 176 | 12.1 | 16 | 12.3 | 2 | 11.8 | 0 | 0.0 | |
55 à 64 ans | Hommes | 111 | 7.6 | 14 | 10.8 | 2 | 11.8 | 0 | 0.0 |
Femmes | 49 | 3.4 | 4 | 3.1 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 161 | 11.1 | 18 | 13.8 | 2 | 11.8 | 0 | 0.0 | |
65 à 74 ans | Hommes | 88 | 6.1 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 |
Femmes | 75 | 5.2 | 2 | 1.5 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 163 | 11.2 | 3 | 2.3 | 0 | 0.0 | 0 | 0.0 | |
75 ans et plus | Hommes | 135 | 9.3 | 12 | 9.2 | 0 | 0.0 | 0 | 0.0 |
Femmes | 106 | 7.3 | 7 | 5.4 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 241 | 16.6 | 19 | 14.6 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | Hommes | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Femmes | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Renseignement non disponible | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Total | Hommes | 792 | 54.5 | 64 | 49.2 | 6 | 35.3 | 0 | 0.0 |
Femmes | 658 | 45.3 | 65 | 50.0 | 11 | 64.7 | 0 | 0.0 | |
Renseignement non disponible | 2 | 0.1 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | |
TOTAL | 1,452 | 100.0 | 130 | 100.0 | 17 | 100.0 | 0 | 0.0 | |
Détails de la page
- Date de modification :